AKT1 and malignant colon neoplasm: Active VD3 treatment also reduced cell proliferation, altered the mitochondrial membrane potential, inhibited the PI3K/Akt/mTOR pathway, and suppressed glycolysis alongside inducing cell cycle arrest and apoptosis in several human colon cancer cell lines [20,21,22,23].